13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31753588 | CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway. | 2020 Apr | 1 |
2 | 31868203 | Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis. | 2020 Jan 31 | 1 |
3 | 32436415 | Downregulation of PTEN mediates bleomycin-induced premature senescence in lung cancer cells by suppressing autophagy. | 2020 May | 2 |
4 | 32550106 | Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways. | 2020 Jun | 1 |
5 | 31527305 | PTEN loss regulates alveolar epithelial cell senescence in pulmonary fibrosis depending on Akt activation. | 2019 Sep 17 | 1 |
6 | 29808357 | IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure. | 2018 Aug | 3 |
7 | 28343070 | The activation of Akt/mTOR pathway by bleomycin in Epithelial-to-mesenchymal transition of human submandibular gland cells: A treatment mechanism of bleomycin for mucoceles of the salivary glands. | 2017 Jun | 2 |
8 | 29079731 | Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. | 2017 Oct 27 | 2 |
9 | 26425798 | A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis. | 2016 Jan | 1 |
10 | 25919965 | Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF. | 2015 Nov | 1 |
11 | 21302298 | TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). | 2011 Nov | 3 |
12 | 19520917 | Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. | 2010 Apr | 7 |
13 | 17507800 | Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. | 2007 Jun 1 | 1 |